3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Buy
67
FNMA Quote, Financials, Valuation and Earnings
Last price:
$6.59
Seasonality move
:
0.03%
Day range:
$6.44 - $6.79
52-week range:
$1.02 - $8.00
Dividend yield:
0%
P/E ratio:
2,990.02x
P/S ratio:
1.27x
P/B ratio:
--
Volume:
3M
Avg. volume:
6.4M
1-year change:
377.54%
Market cap:
$7.6B
Revenue:
$30.9B
EPS (TTM):
$0.00
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $23.7B | $31.5B | $30.7B | $30.3B | $30.9B | |
| Revenue Growth (YoY) | 10.83% | 32.53% | -2.33% | -1.38% | 1.83% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $2.2B | $1.7B | $1.9B | $2B | |
| Other Inc / (Exp) | -$2.1B | $2.6B | $4.5B | $245M | $1.2B | |
| Operating Expenses | $2.1B | $2.2B | $1.7B | $1.9B | $2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14.9B | $27.9B | $16.2B | $22B | $21.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.1B | $5.8B | $3.3B | $4.5B | $4.3B | |
| Net Income to Company | $11.8B | $22.2B | $12.9B | $17.4B | $17B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $11.8B | $22.2B | $12.9B | $17.4B | $17B | |
| Basic EPS (Cont. Ops) | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | |
| Diluted EPS (Cont. Ops) | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Basic Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| Weighted Average Diluted Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $97.6B | $98B | $107.1B | $132.9B | $143.1B | |
| Revenue (Reported) | $23.7B | $31.5B | $30.7B | $30.3B | $30.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $97.6B | $98B | $107.1B | $132.9B | $143.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7B | $7.9B | $7B | $7.6B | $7.2B | |
| Revenue Growth (YoY) | 52.16% | 2.64% | -11.12% | 8.75% | -5.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $534M | $599M | $684M | $511M | $611M | |
| Other Inc / (Exp) | $1.6B | $2.1B | -$609M | $763M | -$531M | |
| Operating Expenses | $534M | $599M | $684M | $511M | $611M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.3B | $5.6B | $4.8B | $5.4B | $4.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3B | $1.2B | $1B | $1.1B | $923M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5B | $4.4B | $3.8B | $4.3B | $3.7B | |
| Basic EPS (Cont. Ops) | $0.00 | $0.00 | -- | -$0.00 | $0.00 | |
| Diluted EPS (Cont. Ops) | $0.00 | $0.00 | -- | -$0.00 | $0.00 | |
| Weighted Average Basic Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| Weighted Average Diluted Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $23.1B | $25.5B | $31.6B | $35.2B | $36.6B | |
| Revenue (Reported) | $7.7B | $7.9B | $7B | $7.6B | $7.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $23.1B | $25.5B | $31.6B | $35.2B | $36.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $26.4B | $31.7B | $29.8B | $30.9B | $30.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $2.3B | $1.8B | $1.7B | $1.9B | |
| Other Inc / (Exp) | $561M | $3.1B | $1.7B | $1.6B | -$81M | |
| Operating Expenses | $2.1B | $2.3B | $1.8B | $1.2B | $1.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $20.6B | $27.2B | $15.4B | $22.6B | $20.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.3B | $5.6B | $3.2B | $4.7B | $4.1B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $16.3B | $21.6B | $12.3B | $18B | $16.3B | |
| Basic EPS (Cont. Ops) | $0.01 | $0.01 | -$0.00 | -$0.00 | $0.00 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.01 | -$0.00 | -$0.00 | $0.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $96.1B | $100.4B | $113.2B | $136.5B | $144.5B | |
| Revenue (Reported) | $26.4B | $31.7B | $29.8B | $30.9B | $30.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $96.1B | $100.4B | $113.2B | $136.5B | $144.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.7B | $7.9B | $7B | $7.6B | $7.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $534M | $599M | $684M | $511M | $611M | |
| Other Inc / (Exp) | $1.6B | $2.1B | -$609M | $763M | -$531M | |
| Operating Expenses | $534M | $599M | $684M | $511M | $611M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.3B | $5.6B | $4.8B | $5.4B | $4.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3B | $1.2B | $1B | $1.1B | $923M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5B | $4.4B | $3.8B | $4.3B | $3.7B | |
| Basic EPS (Cont. Ops) | $0.00 | $0.00 | -- | -$0.00 | $0.00 | |
| Diluted EPS (Cont. Ops) | $0.00 | $0.00 | -- | -$0.00 | $0.00 | |
| Weighted Average Basic Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| Weighted Average Diluted Share | $5.9B | $5.9B | $5.9B | $5.9B | $5.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $23.1B | $25.5B | $31.6B | $35.2B | $36.6B | |
| Revenue (Reported) | $7.7B | $7.9B | $7B | $7.6B | $7.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $23.1B | $25.5B | $31.6B | $35.2B | $36.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $38.3B | $42.4B | $58B | $35.8B | $38.9B | |
| Short Term Investments | $1.7B | $837M | $696M | $564M | $469M | |
| Accounts Receivable, Net | $9.9B | $9.3B | $9.8B | $10.7B | $11.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.4B | $8.4B | $1.5B | $1.4B | $1.8B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $88.6B | $81.7B | $84.6B | $79.2B | $68.5B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $138.2B | $89B | $50.8B | $53.1B | $79.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4T | $4.2T | $4.3T | $4.3T | $4.3T | |
| Accounts Payable | $9.7B | $9.2B | $9.9B | $10.9B | $11.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $21.9B | $12B | $20.1B | $28.2B | $22.8B | |
| Long-Term Debt | $3.9T | $4.2T | $4.2T | $4.2T | $4.2T | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4T | $4.2T | $4.2T | $4.2T | $4.3T | |
| Common Stock | $140.7B | $140.7B | $140.7B | $140.7B | $140.7B | |
| Other Common Equity Adj | -- | $38M | $35M | $32M | $29M | |
| Common Equity | -$114.7B | -$92.6B | -$79.7B | -$62.3B | -$45.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $25.3B | $47.4B | $60.3B | $77.7B | $94.7B | |
| Total Liabilities and Equity | $4T | $4.2T | $4.3T | $4.3T | $4.3T | |
| Cash and Short Terms | $40B | $43.3B | $58.7B | $36.4B | $39.3B | |
| Total Debt | $3.9T | $4.2T | $4.2T | $4.2T | $4.2T | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $26.5B | $36.3B | $60.3B | $12.5B | $39.4B | |
| Short Term Investments | $1.5B | $806M | $1M | $535M | $445M | |
| Accounts Receivable, Net | $10B | $9.4B | $9.8B | $11.1B | $11.6B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.6B | $6B | $2.7B | $2.1B | $1.8B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $103.5B | $70.4B | $99.8B | $99.9B | $85B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $112.8B | $85.4B | $51.1B | $49.9B | $79.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.1T | $4.3T | $4.3T | $4.3T | $4.4T | |
| Accounts Payable | $9.6B | $9.3B | $10.2B | $11.1B | $11.9B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $12.4B | $13.3B | $24.1B | $25.4B | $22.9B | |
| Long-Term Debt | $4T | $4.2T | $4.2T | $4.2T | $4.2T | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4T | $4.2T | $4.3T | $4.2T | $4.3T | |
| Common Stock | $140.7B | $140.7B | $140.7B | $140.7B | $140.7B | |
| Other Common Equity Adj | -- | $31M | $35M | $36M | $23M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $30.2B | $51.8B | $64B | $82B | $98.3B | |
| Total Liabilities and Equity | $4.1T | $4.3T | $4.3T | $4.3T | $4.4T | |
| Cash and Short Terms | $28B | $37.1B | $60.3B | $13.1B | $39.8B | |
| Total Debt | $4T | $4.2T | $4.2T | $4.2T | $4.2T | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.8B | $22.2B | $12.9B | $17.4B | $17B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2.7B | -$618M | -$1.8B | -$1.1B | -$733M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$72.9B | $47.2B | $43.8B | $11.9B | -$10.5B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $26.7B | $90.9B | $90.1B | $99.2B | $157.8B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.7T | $1.4T | $810.7B | $644.8B | $693.6B | |
| Long-Term Debt Repaid | -$1.6T | -$1.6T | -$965.4B | -$774.9B | -$830.8B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$510M | $69M | -- | -- | -$3M | |
| Cash From Financing | $100.5B | -$145.1B | -$154.7B | -$130.2B | -$137.2B | |
| Beginning Cash (CF) | $61.4B | $115.6B | $108.6B | $87.8B | $68.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $54.2B | -$7B | -$20.8B | -$19.1B | $10.1B | |
| Ending Cash (CF) | $115.6B | $108.6B | $87.8B | $68.7B | $78.8B | |
| Levered Free Cash Flow | -$72.9B | $47.2B | $43.8B | $11.9B | -$10.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $24.9B | $3.4B | $4B | $7.1B | $3.5B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.4B | $4.3B | $17.6B | -$12.3B | $24.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $393.8B | $277.9B | $155.9B | $59.9B | $69.8B | |
| Long-Term Debt Repaid | -$405.6B | -$305.3B | -$174.5B | -$90.2B | -$98.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $71M | -- | -- | -- | -$2M | |
| Cash From Financing | -$11.7B | -$27.3B | -$18.6B | -$30.3B | -$28.7B | |
| Beginning Cash (CF) | $115.6B | $108.6B | $87.8B | $68.7B | $78.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3B | -$19.7B | $3B | -$35.5B | -$1B | |
| Ending Cash (CF) | $114.3B | $89B | $90.8B | $33.3B | $77.8B | |
| Levered Free Cash Flow | $24.9B | $3.4B | $4B | $7.1B | $3.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$50.2B | $25.7B | $44.5B | $15B | -$14.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$35.4B | $109.6B | $103.4B | $69.3B | $194.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.7T | $1.3T | $688.7B | $548.7B | $703.6B | |
| Long-Term Debt Repaid | -$1.6T | -$1.5T | -$834.7B | -$690.6B | -$839.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $31M | -- | -- | -- | -- | |
| Cash From Financing | $71.3B | -$160.7B | -$146B | -$141.9B | -$135.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$14.4B | -$25.4B | $1.9B | -$57.6B | $44.5B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$50.2B | $25.7B | $44.5B | $15B | -$14.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $24.9B | $3.4B | $4B | $7.1B | $3.5B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$14.4B | $4.3B | $17.6B | -$12.3B | $24.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $393.8B | $277.9B | $155.9B | $59.9B | $69.8B | |
| Long-Term Debt Repaid | -$405.6B | -$305.3B | -$174.5B | -$90.2B | -$98.5B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $71M | -- | -- | -- | -$2M | |
| Cash From Financing | -$11.7B | -$27.3B | -$18.6B | -$30.3B | -$28.7B | |
| Beginning Cash (CF) | $115.6B | $108.6B | $87.8B | $68.7B | $78.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.3B | -$19.7B | $3B | -$35.5B | -$1B | |
| Ending Cash (CF) | $114.3B | $89B | $90.8B | $33.3B | $77.8B | |
| Levered Free Cash Flow | $24.9B | $3.4B | $4B | $7.1B | $3.5B | |
Get FNMA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FNMA
Sector
P/E ratio
2,990.02x
11.61x
PEG ratio
10,391.47x
0.39x
P/B ratio
--
1.05x
Price / LTM sales
1.27x
2.49x
Growth Metrics
FNMA
Sector
Revenue growth
-5.12%
5.72%
Earnings growth
--
5.63%
Revenue (5-year growth)
7.58%
5.17%
Earnings forecast
--
$0.57
Profitability
FNMA
Sector
Profitability FY 2025
--
$141.1M
Return on invested capital
0.38%
5.41%
Return on assets
0.38%
0.98%
Return on equity
18.05%
9.3%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
30
Balance Sheet
FNMA
Sector
Total cash
$39.8B
$493.9M
Short term investments
$469M
$233.8M
Total assets
$4.3T
$4.1B
Long term debt
$4.2T
$302.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Butterfly Network the Best Small-Cap Stock?
Brought to public trading by an SPAC merger in early…
Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
